Integrin alpha-4 (ITGA4 or CD49d) Antibody - Western Blot Validated

Biological Background

To connect mechanism with measurement, this antibody lets you investigate Integrin alpha-4 (ITGA4) in pathway-driven studies. Integrin alpha-4 is an extracellular or receptor-linked component that coordinates matrix engagement with cytoskeletal remodeling. Many projects interpret this target alongside interacting partners, upstream cues, and downstream readouts.

In some datasets and protocols, it is referenced by the gene symbol ITGA4.

Use in the Laboratory

Comparative experiments can separate expression differences from changes in adhesion structure abundance. Considering complex membership and compartment shifts can clarify whether changes reflect signaling or redistribution.

Depending on the model, researchers may ask whether signal shifts reflect altered abundance, compartment changes, or remodeling of associated complexes.

To keep datasets interpretable, labs often document:

• effects of adhesion inhibitors or matrix composition
• remodeling after changes in substrate or mechanical stress
• focal adhesion versus diffuse membrane distribution

Version Notes

This denaturing-format version is geared toward targets presented after reduction and denaturation, where epitope exposure can shift from native conformations. If your study compares multiple conditions, keep acquisition and processing settings stable to avoid confounding.

If your study spans multiple model systems, it can help to define a shared reference condition for Integrin alpha-4 so cross-sample contrasts stay meaningful.

When interpreting Integrin alpha-4, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

Use the denaturing-format version to relate Integrin alpha-4 (ITGA4) behavior to upstream cues and downstream consequences.